hyaline membrane disease respiratory distress syndrome of the newborn under developed lungs
Conditions
Interventions
Automated control of the FiO2 based on the measured SpO2 during 8 hours.
Sponsors
Erasmus MC, Universitair Medisch Centrum Rotterdam
Eligibility
Age
2 Years to 11 Years
Inclusion criteria
Inclusion criteria: Neonates who require respiratory support and supplemental oxygen therapy
Exclusion criteria
Exclusion criteria: Planned dismissal or transfer to a other hospital within 24 hours
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The main parameter during the study is the time the SpO2 spend within the target range. | — |
Secondary
| Measure | Time frame |
|---|---|
| Secondary outcomes are the number of hyper and hypoxic events, average maximum and minimum SpO2 during these events, number of FiO2 adjustments (manual and automated) and cerebral oxygen saturation. | — |
Countries
Netherlands
Outcome results
None listed